Tailoring the x-ray beam energy spectrum to enhance image quality of new radiography contrast agents based on Gd or other lanthanides

Gadovist, a 1.0-molar Gd contrast agent from Schering AG, Berlin, Germany, in use in clinical MRI in Europe, was evaluated as a radiography contrast agent. In a collaboration with Brookhaven National Laboratory (BNL), Schering AG is developing several such lanthanide-based contrast agents, while BNL evaluates them using different x-ray beam energy spectra. These energy spectra include a 'truly' monochromatic beam (0.2 keV energy bandwidth) from the National Synchrotron Light Source (NSLS), BNL, tuned above the Gd K-edge, and x-ray-tube beams from different kVp settings and beam filtrations. Radiographs of rabbits' kidneys were obtained with Gadovist at the NSLS. Furthermore, a clinical radiography system was used for imaging rabbits' kidneys comparing Gadovist and Conray, an iodinated contrast agent. The study, using 74 kVp and standard Al beam filter for Conray and 66 kVp and an additional 1.5 mm Cu beam filter for Gadovist, produced comparable images for Gadovist and Conray; the injection volumes were the same, while the radiation absorbed dose for Gadovist was slightly smaller. A bent-crystal silicon monochromator operating in the Laue diffraction mode was developed and tested with a conventional x-ray tube beam; it narrows the energy spectrum to about 4 keV around the anode tungsten's K' line. Preliminary beam-flux results indicate that the method could be implemented in clinical CT if x-ray tubes with approximately twice higher output become available.

[1]  J A Seibert,et al.  A comparison of mono- and poly-energetic x-ray beam performance for radiographic and fluoroscopic imaging. , 1994, Medical physics.

[2]  Patrice Cacoub,et al.  Néphrotoxicité des produits de contraste iodés , 1987 .

[3]  J. Idee,et al.  Iodinated contrast media‐induced nephropathy: pathophysiology, clinical aspects and prevention , 1994, Fundamental & clinical pharmacology.

[4]  D N Slatkin,et al.  Single-and dual-energy CT with monochromatic synchrotron x-rays. , 1997, Physics in medicine and biology.

[5]  L. Grodzins,et al.  Optimum energies for x-ray transmission tomography of small samples. Applications of synchrotron radiation to computerized tomography I , 1983 .

[6]  M A Bettmann,et al.  Deaths related to iodinated contrast media reported spontaneously to the U.S. Food and Drug Administration, 1978-1994: effect of the availability of low-osmolality contrast media. , 1997, Radiology.

[7]  Pekka Suortti,et al.  Test of a bent laue double crystal fixed exit monochromator , 1994 .

[8]  D. Rogers,et al.  EGS4 code system , 1985 .

[9]  T Takeda,et al.  High Spatial Resolution CT with a Synchrotron Radiation System , 1994, Journal of computer assisted tomography.

[10]  H. Weinmann,et al.  Pre-clinical evaluation of gadobutrol: a new, neutral, extracellular contrast agent for magnetic resonance imaging. , 1995, European journal of radiology.

[11]  W. Thomlinson,et al.  Monochromatic energy-subtraction radiography using a rotating anode source and a bent Laue monochromator. , 1997, Physics in medicine and biology.

[12]  T. Ege,et al.  Complement Activation and Histamine Release following Administration of Roentgen Contrast Media , 1995, Acta radiologica. Supplementum.

[13]  Xiaoye Wu,et al.  CT with monochromatic synchrotron x rays and its potential in clinical research , 1997, Optics & Photonics.

[14]  C Jacobs,et al.  [Nephrotoxicity of iodine contrast media]. , 1991, La Revue du praticien.

[15]  L. Grodzins,et al.  Critical absorption tomography of small samples: Proposed applications of synchrotron radiation to computerized tomography II , 1983 .

[16]  W. Thomlinson,et al.  X-ray reflectivity of bent perfect crystals in Bragg and Laue geometry , 1990 .

[17]  X. Y. Wu,et al.  The tomography beamline at the National Synchrotron Light Source , 1996 .

[18]  J. P. Stonestrom,et al.  A Framework for Spectral Artifact Corrections in X-Ray CT , 1981, IEEE Transactions on Biomedical Engineering.

[19]  F A Dilmanian.  Computed tomography with monochromatic x rays. , 1992, American journal of physiologic imaging.

[20]  H. D. Zeman,et al.  COMPUTED TOMOGRAPHY USING SYNCHROTRON RADIATION , 1984 .

[21]  William Thomlinson,et al.  Performance evaluation of a bent Laue monochromator , 1990 .

[22]  W Krause,et al.  Ytterbium- and dysprosium-EOB-DTPA. A new prototype of liver-specific contrast agents for computed tomography. , 1996, Investigative radiology.

[23]  Dilmanian Fa,et al.  Computed tomography with monochromatic x rays. , 1992 .

[24]  Jerome B. Hastings,et al.  Computed tomography with monochromatic X rays from the National Synchrotron Light Source , 1991 .

[25]  Xiaojing Huang,et al.  A bent Laue–Laue monochromator for a synchrotron-based computed tomography system , 1999 .

[26]  M A Bettmann,et al.  Nonfatal adverse reactions to iodinated contrast media: spontaneous reporting to the U.S. Food and Drug Administration, 1978-1994. , 1997, Radiology.

[27]  P Spanne.  X-ray energy optimisation in computed microtomography. , 1989, Physics in medicine and biology.

[28]  T. Kozuka,et al.  Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. , 1990, Radiology.

[29]  William Thomlinson,et al.  Implementation of diffraction-enhanced imaging experiments: at the NSLS and APS , 2000 .

[30]  A Meyrier.  [Nephrotoxicity of iodine contrast media]. , 1994, Annales de radiologie.

[31]  E C Lasser,et al.  Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration. , 1997, Radiology.

[32]  R. Katzberg,et al.  Urography into the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity. , 1997, Radiology.